Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients

Amanda Frydendahl(Aarhus University), Claus L. Andersen(Aarhus University), Per Vadgaard Andersen(Odense University Hospital), Claudia Jaensch(Regionshospitalet Herning), Kandasamy Ravi(ID Genomics (United States)), Iman Tavassoly(ID Genomics (United States)), Tenna Vesterman Henriksen(Aarhus University), Ryan Ptashkin(Memorial Sloan Kettering Cancer Center), Danielle Afterman(IBM Research - Haifa), Marijana Nesic(Aarhus University Hospital), Eric J. White(ID Genomics (United States)), Uffe S. Løve(Regionshospitalet Viborg), Dunja Glavaš(ID Genomics (United States)), Tomer Lauterman(IBM Research - Haifa), Michael Yahalom(IBM Research - Haifa), Iver Nordentoft(Aarhus University Hospital), Sia V. Lindskrog(Aarhus University), Lars Dyrskjøt(Aarhus University Hospital), Santiago González(Vir Biotechnology (Switzerland)), Dillon Maloney(ID Genomics (United States)), Kåre Andersson Gotschalck(Regional Hospital Randers), Thomas Reinert(Aarhus University Hospital), Asaf Zviran(Q Therapeutics (United States)), Maja Kuzman(ID Genomics (United States)), Boris Oklander(IBM Research - Haifa), Ury Alon(IBM Research - Haifa), Ole Thorlacius‐Ussing(Aalborg University), Jesper Nors(Aarhus University), James Smadback(ID Genomics (United States)), Lene H. Iversen(Aarhus University Hospital), Mads H. Rasmussen(Aarhus University Hospital), Zohar Donenhirsh(IBM Research - Haifa)

European Journal of Cancer

September 11, 2024

Cited by 19

Related Papers

|Nature|2019|1.5k

|Science Translational Medicine|2017|1.1k

|JAMA Oncology|2019|992

|Nature Genetics|2020|739

|Cancer Cell|2016|654